Dambkowski Carl
Insider CIK 1983476 · APGE Chief Medical Officer · ORKA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 110,665 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 124,962 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 83,690 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer | 2026-09-03 | 2026-09-03 | 167,123 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 83,690 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 124,962 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 110,665 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer | 2026-09-03 | 2026-09-03 | 167,123 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer | 2026-09-02 | 2026-09-03 | 1,375 | $135.06 | $185.7K | 167,123 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer | 2026-09-02 | 2026-09-03 | 1,375 | $135.06 | $185.7K | 167,123 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2026-08-05 | 2026-08-07 | 4,125 | — | $0 | 110,665 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-08-05 | 2026-08-07 | 5,500 | $134.17 | $737.9K | 168,498 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2026-08-05 | 2026-08-07 | 4,125 | $22.86 | $94.3K | 173,998 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2026-08-05 | 2026-08-07 | 4,125 | — | $0 | 110,665 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-08-05 | 2026-08-07 | 5,500 | $134.17 | $737.9K | 168,498 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2026-08-05 | 2026-08-07 | 4,125 | $22.86 | $94.3K | 173,998 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | G Gift | 2026-07-14 | 2026-07-16 | 8,000 | — | $0 | 169,873 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-02 | 4,125 | — | $0 | 114,790 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2026-07-01 | 2026-07-02 | 4,125 | $22.86 | $94.3K | 183,373 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 5,500 | $132.74 | $730.1K | 177,873 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 26,400 | $132.60 | $3.50M | 179,248 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-06-12 | 2026-06-12 | 12,583 | $70.11 | $882.2K | 38,743 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-06-11 | 2026-06-12 | 22,417 | $70.13 | $1.57M | 51,326 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2026-06-03 | 2026-06-05 | 4,125 | — | $0 | 118,915 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-06-03 | 2026-06-05 | 5,500 | $78.71 | $432.9K | 205,648 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2026-06-03 | 2026-06-05 | 4,125 | $22.86 | $94.3K | 211,148 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2026-06-02 | 2026-06-03 | 9,136 | — | $0 | 9,136 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-05-21 | 2026-05-22 | 11,904 | — | $0 | 10,952 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-05-21 | 2026-05-22 | 11,667 | — | $0 | 5,833 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-05-21 | 2026-05-22 | 38,689 | — | $0 | 32,737 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-05-21 | 2026-05-22 | 38,318 | $58.43 | $2.24M | 140,425 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-05-21 | 2026-05-22 | 38,689 | $6.84 | $264.6K | 155,172 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-05-21 | 2026-05-22 | 13,235 | $59.97 | $793.7K | 73,743 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-05-21 | 2026-05-22 | 53,447 | $59.10 | $3.16M | 86,978 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-05-21 | 2026-05-22 | 11,667 | $11.77 | $137.3K | 178,743 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-05-21 | 2026-05-22 | 11,904 | $7.80 | $92.9K | 167,076 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2026-05-06 | 2026-05-08 | 4,125 | — | $0 | 123,040 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-08 | 3,700 | $83.92 | $310.5K | 208,823 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2026-05-06 | 2026-05-08 | 4,125 | $22.86 | $94.3K | 212,523 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-08 | 1,800 | $84.60 | $152.3K | 207,023 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2026-04-01 | 2026-04-03 | 4,125 | — | $0 | 127,165 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2026-04-01 | 2026-04-03 | 4,125 | $22.86 | $94.3K | 213,898 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-03 | 100 | $85.89 | $8.6K | 208,398 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-03 | 2,702 | $85.33 | $230.6K | 208,498 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-03 | 2,698 | $84.31 | $227.5K | 211,200 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2026-03-04 | 2026-03-06 | 4,125 | — | $0 | 131,290 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-06 | 200 | $73.26 | $14.7K | 209,773 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2026-03-04 | 2026-03-06 | 4,125 | $22.86 | $94.3K | 215,273 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-06 | 3,225 | $70.33 | $226.8K | 212,048 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-06 | 2,075 | $71.98 | $149.4K | 209,973 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2026-02-04 | 2026-02-04 | 4,125 | — | $0 | 135,415 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-02-04 | 2026-02-04 | 200 | $68.94 | $13.8K | 211,148 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-02-04 | 2026-02-04 | 1,420 | $65.83 | $93.5K | 212,747 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-02-04 | 2026-02-04 | 1,299 | $66.85 | $86.8K | 211,448 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2026-02-04 | 2026-02-04 | 4,125 | $22.86 | $94.3K | 216,648 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-02-04 | 2026-02-04 | 2,481 | $64.88 | $161.0K | 214,167 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-02-04 | 2026-02-04 | 100 | $67.88 | $6.8K | 211,348 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | J Other | 2026-01-23 | 2026-01-23 | 116,483 | — | $0 | 116,483 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2026-01-07 | 2026-01-09 | 14,025 | — | $0 | 139,540 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-07 | 2026-01-09 | 2,954 | $77.13 | $227.8K | 228,269 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-07 | 2026-01-09 | 100 | $80.06 | $8.0K | 212,523 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-07 | 2026-01-09 | 826 | $79.04 | $65.3K | 212,623 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2026-01-07 | 2026-01-09 | 14,820 | $77.90 | $1.15M | 213,449 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2026-01-07 | 2026-01-09 | 14,025 | $22.86 | $320.6K | 231,223 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 83,690 | — | $0 | 83,690 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-12-04 | 2025-12-05 | 10,900 | $75.00 | $817.5K | 271,108 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2025-11-05 | 2025-11-07 | 8,060 | — | $0 | 153,565 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-11-05 | 2025-11-07 | 678 | $56.51 | $38.3K | 282,008 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-11-05 | 2025-11-07 | 5,607 | $55.58 | $311.6K | 282,686 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2025-11-05 | 2025-11-07 | 8,060 | $22.86 | $184.3K | 292,793 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-11-05 | 2025-11-07 | 2,300 | $53.62 | $123.3K | 290,493 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-11-05 | 2025-11-07 | 2,200 | $54.83 | $120.6K | 288,293 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2025-10-01 | 2025-10-03 | 2,385 | — | $0 | 161,625 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2025-10-01 | 2025-10-03 | 2,385 | $22.86 | $54.5K | 289,843 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-10-01 | 2025-10-03 | 5,110 | $39.80 | $203.4K | 284,733 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-09-03 | 2025-09-05 | 2,535 | $37.82 | $95.9K | 233,738 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-09-03 | 2025-09-05 | 190 | $38.55 | $7.3K | 233,548 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 2,725 | $37.78 | $103.0K | 236,273 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2025-07-02 | 2025-07-03 | 7,365 | — | $0 | 164,010 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-07-02 | 2025-07-03 | 746 | $46.26 | $34.5K | 238,998 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-07-02 | 2025-07-03 | 2,935 | $45.49 | $133.5K | 239,744 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-07-02 | 2025-07-03 | 6,409 | $44.77 | $286.9K | 242,679 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2025-07-02 | 2025-07-03 | 7,365 | $22.86 | $168.4K | 249,088 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-06-04 | 2025-06-06 | 2,725 | $36.96 | $100.7K | 241,723 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2025-06-02 | 2025-06-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-05-07 | 2025-05-09 | 2,725 | $35.75 | $97.4K | 244,448 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-04-02 | 2025-04-04 | 500 | $37.03 | $18.5K | 248,062 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-04-02 | 2025-04-04 | 2,471 | $35.56 | $87.9K | 248,562 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-04-02 | 2025-04-04 | 889 | $37.59 | $33.4K | 247,173 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-03-05 | 2025-03-07 | 1,590 | $30.48 | $48.5K | 251,033 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2025-02-05 | 2025-02-07 | 795 | — | $0 | 171,375 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2025-02-05 | 2025-02-07 | 795 | $22.86 | $18.2K | 256,143 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 3,520 | $40.69 | $143.2K | 252,623 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2025-01-02 | 2025-01-03 | 1,360 | — | $0 | 172,170 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 2,486 | $47.21 | $117.4K | 255,448 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 1,499 | $46.42 | $69.6K | 257,934 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2025-01-02 | 2025-01-03 | 1,360 | $22.86 | $31.1K | 259,433 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 100 | $47.92 | $4.8K | 255,348 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise deriv | 2024-12-11 | 2024-12-13 | 1,815 | — | $0 | 173,530 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | M Exercise | 2024-12-11 | 2024-12-13 | 1,815 | $22.86 | $41.5K | 262,613 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-12-11 | 2024-12-13 | 455 | $50.00 | $22.8K | 258,073 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-12-11 | 2024-12-13 | 4,085 | $48.62 | $198.6K | 258,528 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2024-12-09 | 2024-12-11 | 124,962 | — | $0 | 124,962 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-12-04 | 2024-12-06 | 6,665 | $46.07 | $307.1K | 260,798 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 1,339 | $59.96 | $80.3K | 267,463 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 5,326 | $58.91 | $313.8K | 268,802 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-10-02 | 2024-10-04 | 925 | $56.86 | $52.6K | 274,128 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-10-02 | 2024-10-04 | 5,740 | $56.16 | $322.4K | 275,053 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-09-04 | 2024-09-06 | 787 | $48.06 | $37.8K | 280,793 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-09-04 | 2024-09-06 | 5,878 | $47.49 | $279.1K | 281,580 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-08-07 | 2024-08-09 | 142 | $41.09 | $5.8K | 288,128 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-08-07 | 2024-08-09 | 6,523 | $40.47 | $264.0K | 288,270 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-08-07 | 2024-08-09 | 670 | $42.56 | $28.5K | 287,458 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-07-03 | 2024-07-05 | 3,852 | $37.29 | $143.6K | 296,936 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | S Sale | 2024-07-03 | 2024-07-05 | 2,143 | $38.16 | $81.8K | 294,793 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2023-12-18 | 2023-12-20 | 175,345 | — | $0 | 175,345 | SEC↗ |